SCM
ISEE

Stevens Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Stevens Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-7,757
Closed -$404K – 1276
2015
Q2 		$404K Sell
7,757
-8,499
-52% -$423K 0.01% 674
2015
Q1 		$756K Buy
+16,256
New +$844K 0.03% 474

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stevens Capital Management's ISEE Position: Q3 2015 in Review

Stevens Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2015, closing a stake of 7,757 shares — an estimated $404K sold.

Stevens Capital Management first reported a position in ISEE in Q1 2015 and held it in 2 quarters. The position peaked at $756K in Q1 2015. 144 funds tracked by Wall St. Rank hold ISEE as of Q3 2015.

  • Stevens Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2015 after selling out during the quarter.
  • Stevens Capital Management sold 7,757 IVERIC bio, Inc. Common Stock shares in Q3 2015, an estimated $404K.
  • Stevens Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2015 and held it in 2 quarters.
  • Stevens Capital Management's IVERIC bio, Inc. Common Stock position peaked at $756K in Q1 2015.
  • 144 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2015.

Based on Stevens Capital Management's 13F filing for Q3 2015, filed 10 Nov 2015.